Kurt Von Emster, Director at CymaBay Therapeutics, Inc. (CBAY), sold 157,848 shares at $10.25 ($1.6M) on 2018-01-19, disclosed to the SEC on 2018-01-22.
Open-market sale of $1.6M CBAY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.21 | 13,632 | $139K | 8.6% |
| 2 | $10.21 | 13,632 | $139K | 8.6% |
| 3 | $10.25 | 130,584 | $1.3M | 82.8% |
| Total | $10.24 avg | 157,848 | $1.6M | 100% |
| Filing → |
| VERA | BUY | 2021-05-18 | $8.9M | — | Filing → |
| PCVX | BUY | 2020-06-18 | $200K | — | Filing → |
| CRSP | SELL | 2019-01-18 | $3.7M | — | Filing → |